Fil LTD Neurocrine Biosciences Inc Transaction History
Fil LTD
- $96.6 Billion
- Q1 2025
A detailed history of Fil LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fil LTD holds 4,129 shares of NBIX stock, worth $532,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,129
Previous 14,417
71.36%
Holding current value
$532,186
Previous $1.97 Million
76.82%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.3MCall Options Held
743KPut Options Held
464K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$718 Million0.42% of portfolio
-
State Street Corp Boston, MA4.86MShares$627 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$344 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...